(3S)-3-Amino-N-cyclopropyl-2-hydroxyhexanamide hydrochloride

We are (3S)-3-Amino-N-cyclopropyl-2-hydroxyhexanamide hydrochloride CAS:850252-34-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:(3S)-3-Amino-N-cyclopropyl-2-hydroxyhexanamide hydrochloride
CAS.NO:850252-34-5
Synonyms:(3S)-3-Amino-N-cyclopropyl-2-hydroxyhexanamide hydrochloride
 
Physical and Chemical Properties:
Molecular Formula C9H19ClN2O2
Molecular Weight 222.712
 
Specification:
Appearance:Off-white powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Telaprevir(CAS:402957-28-2).

(3S)-3-Amino-N-cyclopropyl-2-hydroxyhexanamide hydrochloride


Related News: Combining its core technological advantages such as ammonia oxidation, phosgenation, and fluorination, the company actively enters the field of fine and functional chemicals, and expands its focus to include polymer additives, replacement of phenolic polymer material monomers, and coating preservatives.5-bromo-3-nitropicolinonitrilo CAS:573675-25-9 Combining its core technological advantages such as ammonia oxidation, phosgenation, and fluorination, the company actively enters the field of fine and functional chemicals, and expands its focus to include polymer additives, replacement of phenolic polymer material monomers, and coating preservatives.152460-08-7 Combining its core technological advantages such as ammonia oxidation, phosgenation, and fluorination, the company actively enters the field of fine and functional chemicals, and expands its focus to include polymer additives, replacement of phenolic polymer material monomers, and coating preservatives.Dibromomethane CAS:74-95-3 We are pleased that intravenous rigosertib will be made compliantly available to suitable patients with higher-risk MDS through their physicians in designated countries.We are pleased that intravenous rigosertib will be made compliantly available to suitable patients with higher-risk MDS through their physicians in designated countries.

Related Products
Product Name
7-oxo-7-phenylheptanoic acid View Details
3-fluoro-5-iodo-4-methylbenzoic acid View Details
lithium gluconate Cas:60816-70-8 View Details
Dioctylamine Cas:1120-48-5 manufacturer 2-Pyridinecarboxaldehyde Cas:1121-60-4 manufacturer 3-methylquinoline Cas:612-58-8 manufacturer 2,6-DIMETHYLTHIOPHENOL Cas:118-72-9 manufacturer Cyano Temozolomide Cas:114601-31-9 manufacturer